Bridge Laboratories
Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is US owned and headquartered in Gaithersburg, Maryland, with lab facilities in both the US and Beijing, China. Bridge is known for its extensive work in toxicology, including vaccines, developmental and reproductive toxicology (DART), and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide.| Address: | 32 Kexue Yuan Road, Zhonggancun Life Science Park, Changping District, Beijing 102206 |
| Website: | www.bridgelaboratories.com |
| Phone: | +86 10 8072 8800 |
| Fax: | +86 10 8072 9176 |